| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3847688 | American Journal of Kidney Diseases | 2014 | 12 Pages |
Abstract
These results provide some support for the use of lesser eGFR declines as a surrogate end point, with stronger support for the 40% than 30% decline.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Lesley A. MD, MS, Hiddo J. PhD, Hasi MPH, Christopher H. PhD, Hocine MS, Farzad PhD, Josef MD, PhD, Tom PhD, Andrew S. MD,